Nucleic Acid Testing Market Will Hit At A CAGR Of 7.5% From 2017 To 2027

Nucleic Acid Testing Market Projected for Promising Growth Prospects over 2017-2027; Bolstering Diagnosis, Treatment, and R&D to Create Hotspots in Developing Regions


VALLEY COTTAGE, N.Y. , April 26, 2018 (GLOBE NEWSWIRE) -- Nucleic acid testing is a new age testing practice that helps in detection, diagnosis and screening of pathogens even when there is no relative clinical sign for a health condition. Due to the assistance provided by nucleic acid testing to healthcare centres and common public, the market is expected to have positive prospects in coming years. A new research report by Future Market Insights on the global nucleic acid testing market reveals has been titled, ‘Nucleic Acid Testing Market - Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027,’ and assesses the growth prospects of the nucleic acid testing market for the next nine years. The global revenue of nucleic acid testing market are foreseen to reach beyond US$ 4,900 Mn by the end of 2027. Over 2017-2027, the market is expected to expand at a robust CAGR of 7.5%.

Nucleic Acid Testing Market: Overview

Nucleic acid testing is helpful in the detection of the nucleic acids such as viral DNAs or RNAs in specimen samples of the patients. The technique is helpful in providing special assistance to doctors as well as patients. The healthcare industry needs advanced technique to cope with the increasing severity of health related issues that the population is more prone to. Increasing chronic disease incidences due to changing lifestyle have resulted in escalating demand for diagnostic procedures worldwide. Nucleic acid testing kits and consumables are the key products in the in-vitro diagnostic industry, as they have been proven to deliver promising results during critical diagnosis in various applications.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1106

Emerging countries in the Asia Pacific region, such as China and India, are the hotspots for investments because of higher growth rate of diagnosis, treatment and research activities. Future Market Insights expects developing regional markets to experience higher demand for nucleic acid testing over the assessment period. According to the report, North America is expected to hold a market value of over US$ 1,600 Mn by the end of 2027 but APAC is expected to create more incremental opportunities and will reportedly witness a CAGR of 8.6% during the forecast period.

Nucleic Acid Testing Market: Trends

Looking at the recent demands for nucleic acid testing, key manufacturers are now focusing on introducing new custom product offerings for specific needs. Due to the research community’s ever evolving needs, the demand for specialised tools and reagents have grown to the point where most vendors who are currently offering these products cannot depend solely on sales of catalog products. Customised products are likely to trend in near future, creating attractive growth opportunities for emerging businesses.

Preview of Nucleic Acid Testing Market Segmentation by Product Type- Nucleic Acid test Kits (Transcription-mediated amplification (TMA), Polymerase chain reaction (PCR), Ligase chain reaction (LCR), Whole genome sequencing) and Consumables; Indication - Infectious diseases, Cancer, Forensic Testing, Others; End User - Hospitals, Pathology laboratories, Research Institutes, Clinics; Region - North America, Latin America, Western Europe, Eastern Europe, APECJ, China, Japan, and MEA: https://www.futuremarketinsights.com/reports/nucleic-acid-testing-market

The rise in demand has also encouraged many companies to look for expansion of their businesses. Various companies are emphasizing on expansion activities by setting-up their plants and regional offices in developing regions, including APAC and MEA. The competitive scenario of the market is consolidated, and a majority players prefer to involve in sales and service agreements, collaborations, R&D, new product launches, joint ventures, partnerships, patent transfers, and mergers and acquisitions.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-1106

More from FMI’s Healthcare, Pharmaceuticals & Medical Devices:

  • Zika Virus Testing Market Segmentation By Test Type - On-Site/POCT Testing, Rapid IgG/IgM Test Strips, Rapid IgG/IgM Test Cassettes, Rapid IgG/IgM Test Cards, ELISA Kits, Laboratory Tests, Government Funded; By Key Inclusions Type - Zika Introduction, Timeline, Zika Vaccine Under Development, THE 2015 – 2016 ZIKA OUTBREAK, Zika Virus After Travel Prevention; By End Users Type - Hospitals & Clinics, Private Commercial Laboratories, Government/ Publicly Funded Programs: https://www.futuremarketinsights.com/reports/zika-virus-testing-market
  • MEA Hepatitis B Diagnostic Tests Market Segmentation: By Product Type: Enzyme Immunoassay Kits - Hepatitis B Surface Antigen Test, Anti-Hepatitis B Surface Antibody Test, Anti-Hepatitis B Core Antibody Test; Point-of-Care Testing Kits: Strips, Cassettes/Cards; By End User: Hospitals, Clinics, Diagnostic Centres, Home Care: https://www.futuremarketinsights.com/reports/hepatitis-b-diagnostic-test-market

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Browse More: Healthcare, Pharmaceuticals & Medical Devices

Contact Us

Mr. Sudip Saha
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
Press Office: Press@futuremrketinsights.com
FMI Blog: http://www.fmiblog.com/
Website: www.futuremarketinsights.com